|View printer-friendly version|
|August 23, 2005 11:42 a.m.|
|Court Grants Teva Summary Judgment of Non-Infringement on Gabapentin|
Jerusalem, Israel, August 23, 2005 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. District Court for the District of New Jersey has granted summary judgment in Teva's favor on the issue of non-infringement with regard to Pfizer Inc.'s U.S. Patent No. 6,054,482. Other summary judgment motions made by Teva were denied by the Court.